🇺🇸 FDA
Patent

US 11066656

PH20 polypeptide variants, formulations and uses thereof

granted A61KA61K38/00A61K38/28

Quick answer

US patent 11066656 (PH20 polypeptide variants, formulations and uses thereof) held by HALOZYME, INC. expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K38/00, A61K38/28, A61K38/47, A61K45/06